Cargando…
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions
The delivery of specific cytokine payloads to a neoplastic environment employing antibodies able to selectively accumulate at the tumor site represents an attractive strategy to stimulate an immune response to cancer. Whilst conventional antibody–cytokine fusions based on a single payload have shown...
Autores principales: | Prodi, Eleonora, Comacchio, Claudia, Gilardoni, Ettore, Di Nitto, Cesare, Puca, Emanuele, Neri, Dario, De Luca, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123652/ https://www.ncbi.nlm.nih.gov/pubmed/37092450 http://dx.doi.org/10.3390/antib12020029 |
Ejemplares similares
-
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties
por: Di Nitto, Cesare, et al.
Publicado: (2023) -
Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21
por: Di Nitto, Cesare, et al.
Publicado: (2022) -
Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody
por: Nadal, Lisa, et al.
Publicado: (2022) -
Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction
por: Grillo, Federica, et al.
Publicado: (2020) -
Accuracy of Magnetic Resonance Spectroscopy in Discrimination of Neoplastic and Non-Neoplastic Brain Lesions
por: Alshammari, Qurain T., et al.
Publicado: (2021)